Summit Biosciences' Series A - II Round

Summit Biosciences raised a round of funding on August 01, 2012. Investors include Yearling Fund.

Summit Biosciences is a specialty pharmaceutical company focused on developing, manufacturing and commercializing generic and innovative nasal spray drug products. The company provides contract develo…

Articles about Summit Biosciences' Series A - II Round: